Skip to main content

Latest SEC Filings — Page 79

Page 79 · 30 filings scored 7+ · newest 7:21 AM ET · How scores work

Wed, Oct 2127 filings
7WSWorthington Steel, Inc.Worthington Steel Sets One-Year Freeze If Kloeckner DPLTA Vote FailsForm 8-K · Current report● Neutral8INVEINVE Technologies, Inc.INVE Launches $20M Dutch Auction Tender at $2.85-$3.40; Prelim Q3 Revenue $2.9-$3.1MForm 8-K · Current report▲ PositivePro7WABWestinghouse Air Brake Technologies CorporationWabtec Beats on Q3, Raises 2026 Adjusted EPS Guidance to $10.85-$11.05Form 8-K · Current report▲ Positive7ONBOld National BancorpOld National Posts Record Q3: $0.66 EPS, 46.1% Efficiency Ratio, $100M BuybackForm 8-K · Current report▲ Positive8ROIVRoivant Sciences Ltd.Roivant's Brepocitinib Meets Primary Endpoint in Both Phase 3 NIU TrialsForm 8-K · Current report▲ PositivePro7PMPhilip Morris International Inc.PMI Q3 Beats on Revenue and Organic Growth; Full-Year EPS Forecast Trimmed to $8.29-$8.44Form 8-K · Current report● Neutral7HCSGHealthcare Services Group, Inc.HCSG Q3 EPS $0.36; Raises 2027 Revenue Growth Outlook to Low Double-DigitsForm 8-K · Current report▲ Positive8NTZNatuzzi S.p.A.Natuzzi Q2 Loss Widens to €10M as Sales Fall 23%; New CEO Starts Oct 26Form 6-K · Current report▼ NegativePro7GOWGOWell Energy TechnologyGOWell Posts First Post-SPAC Results: Revenue Up 43%, FY26 Guidance ReiteratedForm 6-K · Current report▲ Positive7SFStifel Financial Corp.Stifel Q3 EPS Hits Record $1.46, But Institutional Revenue Slides 14%Form 8-K · Current report● Neutral8BGXBlackstone Long-Short Credit Income FundSaba Capital Discloses 5.87% Activist Stake in Blackstone Long-Short Credit Income FundSchedule 13D · Ownership stake▲ PositivePro7PBMPsyence Biomedical Ltd.Psyence Completes US$2.6M PsyLabs Backstop as Ibogaine Milestones MetForm 6-K · Current report● Neutral7MCOMoody's CorporationMoody's Q3 Revenue Up 1% to $2.0B, EPS Up 18%, FY26 Guidance ReaffirmedForm 8-K · Current report● Neutral8SHMDSCHMID Group N.V.SCHMID Lifts Order Intake Guidance Above €150M as Q3 Orders Hit RecordForm 6-K · Current report▲ PositivePro9TRADAPEX Tech Acquisition Inc.APEX Tech Signs $3.5B Merger With Korai Flix, To Rename Krflix GroupForm 8-K · Current report▲ PositivePro7NVANova Minerals CorpU.S. Government Commits $249M to Port MacKenzie Rail Extension Serving Nova's Antimony SiteForm 8-K · Current report▲ Positive7NTRSNorthern Trust CorporationNorthern Trust Q3 EPS $3.40, Up 48% YoY; Dividend Raised to $0.88Form 8-K · Current report▲ Positive8TAT&T Inc.AT&T Q3 Beats: Adjusted EPS $0.65, 2026 Outlook Raised, Capex CutForm 8-K · Current report▲ PositivePro7IARTIntegra LifeSciences Holdings CorporationIntegra Q3 EPS Beat; 2026 Guidance Reaffirmed After $2.1B RefinancingForm 8-K · Current report● Neutral7SVAQSilicon Valley Acquisition Corp.EigenQ Adds Up to $5M Subordinated Unsecured Notes Junior to September Secured FinancingForm 8-K · Current report▼ Negative7DRDDRDGOLD LTDDRDGOLD Q1 FY2027: Revenue Up 31%, Operating Profit Up 42%, Debt-FreeForm 6-K · Current report▲ Positive9LABStandard BioTools Inc.Standard BioTools S-4/A Sets Vote on Treeline Reverse Merger and $5.5M Mass Cytometry SaleForm S-4/A● NeutralPro8WDSWoodside Energy Group LtdWoodside Q3 Revenue Up 27% to $4.28B; Production Guidance Narrowed, Calypso Sold to bpForm 6-K · Current report▲ PositivePro7ATHEAlterity Therapeutics LtdAlterity AGM Seeks 25% Placement Capacity, Director Options and Auditor Swap to BDOForm 6-K · Current report▼ Negative7AITXArtificial Intelligence Technology Solutions Inc.AITX Q2 FY2027: Non-Top-Customer Revenue Up 61% YoY, Revenue Up 8% SequentiallyForm 8-K · Current report● Neutral8ELVElevance Health, Inc.Elevance Beats Q3, Raises FY26 EPS Guidance to at Least $29.00Form 8-K · Current report▲ PositivePro8BURUNuburu, Inc.Nuburu Closes 70% Tekne Buy for €5.2M Plus €20M Earn-Out; NYSE Issues Delisting WarningForm 8-K · Current report▼ NegativePro
Tue, Oct 203 filings
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.